TTC29, or Tetratricopeptide Repeat Domain 29, is a protein encoded by the TTC29 gene. The "tetratricopeptide repeat" in its name refers to a structural motif that is frequently involved in protein-protein interactions. Proteins containing such motifs, including TTC29, typically serve as scaffolds, mediating the assembly of complex protein structures or facilitating interactions between various proteins. With this general role of TPR-containing proteins, TTC29 is likely involved in specific protein-protein interactions within the cell, aiding in the formation or regulation of multi-protein complexes.
TTC29 inhibitors would be molecules or strategies designed to impede the function, expression, or stability of the TTC29 protein. Inhibitors might disrupt the protein-protein interactions mediated by TTC29, thereby affecting the formation or function of multi-protein complexes in which TTC29 is involved. Such inhibitors could include small molecules that hinder TTC29's ability to bind to its interaction partners, antisense oligonucleotides targeting its mRNA to decrease its expression, or agents that impact its post-translational modifications, altering TTC29's stability or interaction capabilities. Investigating the effects of inhibiting TTC29 can offer insights into its specific roles within cells and deepen our understanding of the intricate network of protein interactions and complexes it may be part of.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis. This action could potentially inhibit the transcription of the TTC29 gene, leading to decreased expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks eukaryotic protein synthesis. By inhibiting translation, it could reduce TTC29 protein levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-FU affects RNA processing and function. Its action might indirectly suppress TTC29 gene transcription or mRNA stability. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. Given PI3K's role in various cellular processes, its inhibition might indirectly downregulate TTC29 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor. MAPK/ERK pathways could be involved in various cellular processes, and its inhibition might influence TTC29 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid impacts cellular differentiation processes. It might influence TTC29 expression during specific developmental stages. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, potentially impacting protein synthesis and stability, which could lead to reduced TTC29 levels. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea interferes with DNA synthesis. It could potentially impact the proliferation of cells and thereby TTC29 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has roles in modulating gene expression in certain contexts. It might indirectly influence TTC29 expression in specific cells. | ||||||